Sitemap

STADA achieved strong results in the first half of 2019

The Annual Assembly of the Slovenian Business Club Held

On March 25th, the annual assembly of...

BYD Overtakes Tesla in Revenue

Chinese EV giant BYD surpasses Tesla in...

Sanofi Strengthens Immunology Portfolio with $1.9 Billion Acquisition of Dren Bio’s Unit

Sanofi, the French multinational pharmaceutical giant, has...

SAP SE Overtakes Novo Nordisk in Value

SAP SE’s rise to the top spot...

CorD Recommends

Klaus Schwab Steps Down Amid Allegations

After more than five decades at the helm of the World Economic Forum, Klaus Schwab, the founder who played...

Print Still Reigns in Europe

In an era dominated by screens and streaming, the allure of ink on paper continues to charm European readers. According...

Meeting of the Strategic Board of the Western Balkans Investment Framework

The meeting of the Strategic Board of the Western Balkans Investment Framework (WBIF), chaired by Croatia, began this morning...

Serbian Economy Slows Sharply Amid EU Stagnation, Warns wiiw Economist

Serbia’s economy is experiencing a marked slowdown, primarily driven by the stagnation of Germany and other European Union economies,...

World Book and Copyright Day

Each year, on April 23rd, UNESCO celebrates World Book and Copyright Day to highlight the power of books to bring together...

With record sales growth of 11 per cent in the first half of this year, Stada’s performance is well above the industry average.

The Stada Group, within which Hemofarm operates, continues to grow significantly, achieving strong results in the first half of 2019. Reported consolidated sales increased 11 per cent in the first half of 2019 to 1.26 billion Euros (2018: Euro 1.14 billion).

On this occasion, Peter Goldschmidt, CEO of Stada, said: “We are particularly pleased that Stada is experiencing strong growth in both our core segments – branded products / OTC and generics, including pharmaceutical specialities.”

Stada saw strong sales growth and significant market share gains in key European markets, including Germany, the United Kingdom, Italy, Spain and France. The company also recorded good growth in the areas of northern and eastern Europe as well as in Asia / the Middle East. In the first half of this year, Stada continued to invest in production capacity and supply chain. As part of the overall optimization of the production network, the company recently opened a new factory in Vietnam with a capacity of four billion tablets. This production site meets the latest GMP EU quality standards so that Stada can supply the European market from Vietnam in the future.

Related Articles

Stada Group

Year That Changed Europe’s Health Picture

Europeans have confirmed the clear impact of the pandemic on the mental state of citizens: one in four people feels restless, while even more...

Ronald Seeliger, President Of The German-Serbian Chamber Of Commerce

We Can Still Do Wonders

You don't need to be a businessman to know that the shortfalls in production during the spring will affect balance sheets for 2020. However,...

Sanda Savić, Director of Communications at Hemofarm

Success is Unlocked By Words & Confirmed By Images

Hemofarm is a regional leader in the pharmaceutical industry, with record volumes of production, a record number of products and record sales, but it...

Ronald Seeliger, President of the German-Serbian Chamber of Commerce

Strong Bonding

Many German companies have been investing repeatedly in Serbia, expanding their production capacities, creating additional jobs and growing year on year. This commitment and...

Marina Mitić Jekić, HR Director, STADA CEE Region and Hemofarm a.d.

Dedication is Always Rewarded With Trust

As of this May, the Faculty of Technology Novi Sad has launched an event that it will organise annually entitled “Hemofarm Day”, which emerged...

Hemofarm – Repeating our records and raising the bar

Hemofarm, a regional leader in the pharmaceutical industry, will finish this year successfully: the company has confirmed last year's record in the production of...

International Award For Hemofarm Foundation Campaign

‘Don’t let it Burst’, the campaign of Hemofarm Foundation for prevention of high blood pressure, was awarded the Silver Drum award in the category...

Hemofarm at the UN debate: More than half of our employees are women

Hemofarm is the only company from Serbia and this part of Europe that has had the opportunity to participate in this year's UN Debate...